IP Support for Stent Tek Ltd.

在肾衰竭患者中，透析机连接到血管通路（VA）部位以过滤血液。目前，即使是最好的VA方法也有很高的失败率。堵塞的进入部位对患者的生命构成严重危险，并且需要昂贵且可能痛苦的手术来修复。我们的新型导管器械通过微创手术创建了一个更可靠的穿刺部位，使更多的患者可以使用，并降低了医疗保健系统的成本。创新英国基金将帮助我们创建一个专业的专利组合。这对于我们的技术的进一步发展和商业化是必要的，并将确保尽可能多的患者能够从我们的技术中受益。

In patients with kidney failure a dialysis machine hooks up to a vascular access (VA) site to filter their blood. Currently, even the best method for VA has a high failure rate. A clogged access site presents a serious danger to the patient’s life and requires costly and potentially painful surgery to repair. Our novel catheter device creates a more reliable access site through a minimally invasive procedure that makes it accessible to more patients and reduces cost for the healthcare system. Innovate UK funding will help us create a professional patent portfolio. This is necessary in our path toward the further development and commercialization of our technology and will ensure that as many patients as possible will be able to receive the benefits of our technology.